ROCKVILLE, Md.--(BUSINESS WIRE)--Celera (NYSE: CRA), an Applera Corporation business, today announced the publication of data from its research studies identifying several candidate genetic markers associated with late-onset Alzheimer’s disease (LOAD), including markers in multiple genes that have never been associated with LOAD. Two of these genes are PCK1, a gene that regulates blood glucose levels, and GALP, a gene that is modulated by insulin and regulates food intake, suggesting a link between Alzheimer’s disease and irregular glucose/insulin levels. This research paper has been accepted for publication in Human Molecular Genetics and is currently available on the publication’s website at http://hmg.oxfordjournals.org.
